Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has shared an update.
Jubilant Pharmova Limited has notified its shareholders about the transfer of unclaimed dividends and equity shares to the Investor Education and Protection Fund (IEPF) as per regulatory requirements. Shareholders with unclaimed dividends for seven consecutive years, starting from the financial year 2017-18, are urged to claim their dividends before the due transfer date of November 1, 2025, to avoid their shares being moved to the IEPF. This action underscores the company’s adherence to compliance regulations and impacts shareholders who have not claimed their dividends, potentially affecting their equity holdings.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of a wide range of pharmaceutical products. The company is known for its contributions to healthcare and pharmaceuticals, serving various markets with its diverse product portfolio.
Average Trading Volume: 17,175
Technical Sentiment Signal: Buy
Current Market Cap: 190B INR
For a thorough assessment of JUBLPHARMA stock, go to TipRanks’ Stock Analysis page.